Commodore Capital LP
Top Portfolio Positions
36 positions ·
$1,916,649,211 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
8,075,940 | $316,576,848 | 16.52% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
17,000,000 | $169,150,000 | 8.83% | |
| ALKS |
Alkermes plc.
Healthcare
|
4,200,000 | $148,512,000 | 7.75% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
2,888,007 | $111,159,389 | 5.80% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
1,912,380 | $96,460,447 | 5.03% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
2,475,000 | $94,792,500 | 4.95% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
2,696,616 | $85,536,659 | 4.46% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
833,600 | $85,402,320 | 4.46% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
5,650,000 | $78,535,000 | 4.10% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
750,000 | $62,467,500 | 3.26% |
Portfolio Trend
22 quarters · across all stocks
Holdings in CLDX
Shares Held
Position Value (USD)
21 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $85,536,659 | 2,696,616 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $69,665,400 | 2,565,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $78,343,026 | 3,028,335 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $70,207,500 | 3,450,000 | Shares | Sole | 2025-08-14 | |
| 2025-04-03 | $57,452,500 | 3,350,000 | Shares | Sole | 2025-04-10 | |
| 2025-03-31 | $58,080,000 | 3,200,000 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $55,027,668 | 1,618,937 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $52,739,250 | 1,425,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,365,661 | 866,468 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,840,011 | 701,967 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,447,420 | 706,665 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,432,393 | 631,665 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,839,711 | 495,823 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,098,831 | 495,823 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,146,005 | 538,812 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,526,371 | 538,812 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,215,237 | 241,199 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $13,400,695 | 248,207 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,815,733 | 323,437 | Shares | Sole | 2021-10-14 | |
| 2021-03-31 | $7,620,990 | 369,951 | Shares | Sole | 2021-10-14 | |
| 2020-12-31 | $6,244,671 | 356,431 | Shares | Sole | 2021-02-16 | |
| No 13F history on record for this holder in this stock. | ||||||